Biosimilar Medicines: Information for specialists.
This activity addresses the following learning outcomes using a combination of reading and active listening to video content.
Upon completion of this activity, participants will be able to:
Explain how biosimilar medicines contribute to the sustainability of the Australian healthcare system.
Outline the clinical development and regulatory processes required prior to approval of biosimilar medicines.
Explain to patients what a biosimilar medicine is, why it is different to a generic medicine, and their therapeutic equivalence to the reference biological product.
Manage patient concerns and queries surrounding biosimilar medicines.
Define the criteria that must be met in order to substitute a PBS-subsidised reference biological for a biosimilar medicine.